| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 08/22/2000 | US6107541 PRAD1 transgenic mice |
| 08/22/2000 | US6107540 Mice models of human prostate cancer progression |
| 08/22/2000 | US6107073 Kinase capable of site-specific phosphorylation of IκBα |
| 08/22/2000 | US6107069 Nucleotide and amino acid sequences; for cloning; for hybridization probes to screen libraries |
| 08/22/2000 | US6107041 Detecting modulators of inhibitor of apoptosis; incubating cell that expresses inhibitor of apoptosis with modulator, monitor the expression of inhibitor of apoptosis, increase in apoptosis is indicator of the presence of a modulator |
| 08/22/2000 | US6105535 Ant habitat with retainer lip |
| 08/17/2000 | WO2000047734A1 Inhibiting formation of atherosclerotic lesions |
| 08/17/2000 | WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation |
| 08/17/2000 | WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 08/17/2000 | WO2000047610A2 Method for altering undesirable immune responses to polypeptides |
| 08/17/2000 | WO2000047219A2 Methods and reagents for treating glucose metabolic disorders |
| 08/17/2000 | WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 08/17/2000 | WO2000005393A3 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 08/17/2000 | CA2362368A1 Method for altering undesirable immune responses to polypeptides |
| 08/17/2000 | CA2361335A1 Inhibiting formation of atherosclerotic lesions |
| 08/17/2000 | CA2360324A1 Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets |
| 08/17/2000 | CA2359785A1 .beta.-secretase enzyme compositions and methods |
| 08/16/2000 | EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/16/2000 | EP1027432A2 RIBOZYMES TARGETED TO IL-15 mRNA |
| 08/16/2000 | EP1027429A1 Jnk3 modulators and methods of use |
| 08/10/2000 | WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals |
| 08/10/2000 | WO2000046240A2 Polypeptides involved in immune response |
| 08/10/2000 | WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor |
| 08/10/2000 | WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/10/2000 | WO2000004190A9 Evolution of whole cells and organisms by recursive sequence recombination |
| 08/10/2000 | WO2000002997B1 Transgenic mouse expressing green fluorescent protein in astrocytes |
| 08/10/2000 | CA2362126A1 B7rp-1 polypeptides |
| 08/09/2000 | EP1026251A2 Transgenic animals expressing human P25 |
| 08/09/2000 | EP1025244A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 08/09/2000 | EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods |
| 08/09/2000 | EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods |
| 08/09/2000 | EP1025233A2 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
| 08/09/2000 | EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF |
| 08/09/2000 | EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 08/09/2000 | EP1025203A1 Impaired brca2 function in cells and non-human transgenic animals |
| 08/09/2000 | EP0556171B1 Growth hormone antagonists |
| 08/09/2000 | CN1262034A Culture method for artificially raised Baijin worm |
| 08/08/2000 | US6100445 Hybrid rodent with homogeneity for cytokine mutation; for prevention of apoptosis; antiproliferative agents |
| 08/08/2000 | US6100444 Nucleotide sequences coding prostate gland protein; for the treatment of prostate cancer |
| 08/08/2000 | US6100088 Viral vaccines |
| 08/08/2000 | US6100046 Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit |
| 08/08/2000 | CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle |
| 08/03/2000 | WO2000044889A2 Mammal with inducible ductal carcinoma in situ |
| 08/03/2000 | WO2000044888A2 Dimethylarginine dimethylaminohydrolases |
| 08/03/2000 | WO2000044881A1 ORGANS FOR TRANSPLANTATION INDUCED $i(IN VITRO) |
| 08/03/2000 | WO2000044879A1 Aggressive prostate cancer sublines selected by androgen deprivation |
| 08/03/2000 | WO2000044786A1 Novel potassium channels and genes encoding these potassium channels |
| 08/03/2000 | WO2000044768A2 Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use |
| 08/03/2000 | WO2000044395A1 Methods and compositions for modulating fertility |
| 08/03/2000 | WO2000024415A3 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 08/03/2000 | WO1998017782A8 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| 08/03/2000 | CA2468453A1 Method of preparing a transgenic non-human animal expressing p25 |
| 08/03/2000 | CA2361271A1 Methods and compositions for modulating fertility |
| 08/02/2000 | EP1023453A2 Tgc method for inducting targeted somatic transgenesis |
| 08/02/2000 | EP1023442A1 Vectors comprising a magnum-specific promoter for avian transgenesis |
| 08/02/2000 | EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 08/02/2000 | CN1261513A Multiple layer mechanized turtle and tortoise cultivation |
| 08/01/2000 | US6096876 1-α-hydroxylase materials and methods |
| 08/01/2000 | US6096866 Netrins |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | CA2184004C Production of fibrinogen in transgenic animals |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043422A1 Methods for generating phosphorylation site-specific immunological reagents |
| 07/27/2000 | WO2000043410A2 Novel odorant receptors in drosophila |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000004157A3 Cloning and characterisation of novel mammalian peptidases |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2358963A1 Cancer-associated proteins |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1021717A1 Method of sorting birds in ovo |
| 07/26/2000 | EP1021550A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 07/26/2000 | EP1021546A1 Neutral sphingomyelinase |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 07/26/2000 | EP1021534A1 Hepatitis c receptor protein cd81 |
| 07/26/2000 | EP1021083A1 A method for increasing incorporation efficiency of omega-3 highly unsaturated fatty acid in poultry meat |
| 07/26/2000 | EP0971603A4 Artificial media for rearing entomophages |
| 07/26/2000 | CN1260954A Pig embryo regulation factor and its preparing process and application |
| 07/25/2000 | US6093872 Human fetal liver tissue and human fetal thymus is introduced into a vascularized site of an immunocompromised mouse at a site supplied with a vascular system; the fetal tissue results in formation of functional human bone marrow tissue |
| 07/25/2000 | CA2049325C Peptide, immunogenic composition and vaccine or medicinal preparation; a method immunising a mammal against lhrh, and a method of improving the meat quality of pigs |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042174A1 Double nuclear transfer method and results thereof |
| 07/20/2000 | WO2000015772A3 Recombinant protein production in urine |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | CA2360549A1 Double nuclear transfer method and results thereof |
| 07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/19/2000 | EP1019520A1 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 07/19/2000 | EP1019509A2 Protein involved in abscisic acid signalling |
| 07/19/2000 | EP1019504A1 Isoforms of the human vitamin d receptor |
| 07/19/2000 | EP1019495A1 Transgenic model comprising tcr alpha and beta chains |
| 07/19/2000 | EP1019491A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP0900002A4 H2-m modified transgenic animals |
| 07/19/2000 | CN2387727Y Solar cockroach breeding box |
| 07/19/2000 | CN1260109A Production of hybrid fingerling for high-yield crucian carp |
| 07/18/2000 | US6091000 SCID mouse engrafted with human synovium tissue |
| 07/18/2000 | US6090620 Genes and gene products related to Werner's syndrome |
| 07/18/2000 | US6090569 Selection of livestock using IGF levels |
| 07/13/2000 | WO2000040719A2 Tissue repair protein involved in orofacial clefting and uses thereof |